| Literature DB >> 20717123 |
Konstantinos Stellos1, Victoria Panagiota, Andreas Kögel, Thomas Leyhe, Meinrad Gawaz, Christoph Laske.
Abstract
Vascular risk factors contribute to the progression of dementia in Alzheimer's disease (AD) and influence platelet activation. However, the degree of platelet activation as a possible underlying mechanism of this progression has not been studied till now. Significantly higher baseline expression of both platelet activation biomarkers, activated glycoprotein IIb-IIIa complex and P-selectin, was observed in patients with AD with fast cognitive decline compared with AD patients with slow cognitive decline during a 1-year follow-up period. These results suggest that platelet activation could be a putative prognostic biomarker for the rate of cognitive decline and a potential new treatment target in AD patients.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20717123 PMCID: PMC3023934 DOI: 10.1038/jcbfm.2010.140
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200